国产日韩欧美,日韩在线中文字幕有码中文,日本妇人成熟免费,欧美牲交作爱在线aav

EN
News Releases

News Releases

Headlines

Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the Consistency Evaluation of Quality and Efficacy of Generic Drugs

Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the...

CR Double-Crane announced on January 22nd that its wholly-owned subsidiary Double-Crane Pharmaceutical (Anhui) received the Approval Document from the National Medical Products Administration (“NMPA”) on Drug Supplementary Applica...
CR Double-Crane announced on January 22nd that its wholly-owned subsidiary Double-Crane Pharmaceutical (Anhui) received the Approv...

Detailed>>

Detailed +

2022.01

2022.01.22

Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the Consistency Evaluation of Quality and Efficacy of Generic Drugs

Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the...

CR Double-Crane announced on January 22nd that its wholly-owned subsidiary Double-Crane Pharmaceutical (Anhui) received the Approval Document from the National Medical Products Administration (“NMPA”) on Drug Supplementary Application for Metronidazole and Sodium Chloride Injection (100ml) on January 5th (Document No.: 2022B00015), which marked that the drug had passed the consistency evaluation of quality and efficacy of generic drugs.

CR Double-Crane announced on January 22nd that its wholly-owned subsidiary Double-Crane Pharmaceutical (Anhui) received the Approv...

2021.11

2021.11.12

Novel Cancer Drug of CR Double-Crane Released and the Signing Ceremony between Haikou National Hi-tech Zone and CR Double-Crane Convened

Novel Cancer Drug of CR Double-Crane Released and the Signing Ceremony betw...

At 9: 00 on November 11, 2021, a novel cancer drug was released by CR Double-Crane, and the signing ceremony between the company and Haikou National Hi-tech Industrial Development Zone was held in the office building of Haikou Municipal Government.

At 9: 00 on November 11, 2021, a novel cancer drug was released by CR Double-Crane, and the signing ceremony between the company a...

2021.10

2021.10.09

NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC

NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC

Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Notice of Drug Clinical Trial Approval from the National Medical Products Administration (NMPA), approving its clinical trials of the NIP142 capsules for non-small cell lung cancer (NSCLC).

Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the No...

2021.10

2021.10.08

A Delegation Led by Zhang Boli Visiting CR Sanjiu

A Delegation Led by Zhang Boli Visiting CR Sanjiu

A Delegation Led by Zhang Boli Visiting CR Sanjiu

A Delegation Led by Zhang Boli Visiting CR Sanjiu

2021.08

2021.08.04

CR Double-Crane’s Sodium Valproate Tablets Fluconazole and Sodium Chloride Injection Passing Consistency Evaluation of Generic Drugs

CR Double-Crane’s Sodium Valproate Tablets Fluconazole and Sodium Chloride ...

CR Double-Crane’s Sodium Valproate Tablets Fluconazole and Sodium Chloride Injection Passing Consistency Evaluation of Generic Drugs

CR Double-Crane’s Sodium Valproate Tablets Fluconazole and Sodium Chloride Injection Passing Consistency Evaluation of Generic Dru...

2021.07

2021.07.12

CR Biopharmaceutical and Biocytogen reach a comprehensive strategic cooperation for the development of multiple target antibody drugs

CR Biopharmaceutical and Biocytogen reach a comprehensive strategic coopera...

On July 12, China Resources Biopharmaceutical Co., Ltd. (hereafter referred to as CR Biopharmaceutical) and Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (hereafter referred to as Biocytogen) reached comprehensive strategic cooperation.

On July 12, China Resources Biopharmaceutical Co., Ltd. (hereafter referred to as CR Biopharmaceutical) and Biocytogen Pharmaceuti...

2021.07

2021.07.07

CR Pharmaceutical’s proposed acquisition of a controlling stake in Boya Bio-pharmaceutical[2019 report] was approved by the SASAC

CR Pharmaceutical’s proposed acquisition of a controlling stake in Boya Bio...

CR Pharmaceutical’s proposed acquisition of a controlling stake in Boya Bio-pharmaceutical?was approved by the SASAC.

CR Pharmaceutical’s proposed acquisition of a controlling stake in Boya Bio-pharmaceutical?was approved by the SASAC.
1 2 3 ... 5 Next
Back to Top
      
      

      <ul id="9ehld"></ul>
      
      <bdo id="9ehld"></bdo>

    1. 主站蜘蛛池模板: 麻城市| 拉萨市| 永州市| 鸡泽县| 苍梧县| 兴山县| 隆昌县| 加查县| 宁河县| 浠水县| 化州市| 莱阳市| 潜山县| 芮城县| 佛学| 清水县| 含山县| 略阳县| 台前县| 木兰县| 汝阳县| 柳河县| 佛坪县| 顺义区| 灵石县| 黄龙县| 伊春市| 商都县| 阿图什市| 义马市| 铅山县| 扶沟县| 安达市| 息烽县| 监利县| 德格县| 交城县| 丰镇市| 泰宁县| 平昌县| 类乌齐县|